Literature DB >> 21601294

In situ characterization of the granulomatous immune response with time in nonhealing lesional skin of Leishmania braziliensis-infected rhesus macaques (Macaca mulatta).

Camila Souza-Lemos1, Simone Neves de-Campos, Antonio Teva, Renato Porrozzi, Gabriel Grimaldi.   

Abstract

We have recently introduced a macaque (Macaca mulatta) model of Leishmania braziliensis-induced self-healing cutaneous leishmaniasis in which the T cell-mediated inflammatory response effectively promotes parasite clearance and granuloma resolution. Here we show that macaques infected with a highly pathogenic L. braziliensis strain displayed longstanding granulomatous lesions which lasted until the end of the observation period (52 weeks). Immunoperoxidase staining of representative tissue sections indicated that distinct cell populations (CD3, CD4, CD8, CD20, Foxp3, CD20, CD68, HLA-DR, CCL2, and CXCL-10) change uniformly during infection, suggesting that the same components of the local immune response are working in unison. This model also confirmed that granuloma formation is orchestrated by diverse inflammatory mediators that are important for T helper type 1 (Th1) cell development and macrophage effector functions. Cytometry analysis of ex vivo granuloma-derived leukocytes revealed accumulation of distinct functional subsets of effector and regulatory T cells into the inflamed skin. We provide evidence that local interleukin (IL)-10 production by both Foxp3(+) and Foxp3(-) CD4(+) T subsets is likely important in promoting lesional granuloma maintenance. Further studying the immune suppression mechanisms that induces granulomas in L. braziliensis-infected macaques may reveal new opportunities for therapeutic control of this important human disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21601294     DOI: 10.1016/j.vetimm.2011.05.002

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  10 in total

1.  Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16(+) monocyte population via the IL-10/STAT3 axis.

Authors:  Claire Lastrucci; Alan Bénard; Luciana Balboa; Karine Pingris; Shanti Souriant; Renaud Poincloux; Talal Al Saati; Voahangy Rasolofo; Pablo González-Montaner; Sandra Inwentarz; Eduardo Jose Moraña; Ivanela Kondova; Frank A W Verreck; Maria del Carmen Sasiain; Olivier Neyrolles; Isabelle Maridonneau-Parini; Geanncarlo Lugo-Villarino; Céline Cougoule
Journal:  Cell Res       Date:  2015-10-20       Impact factor: 25.617

2.  Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species.

Authors:  Daniel Rodriguez-Pinto; Adriana Navas; Víctor Manuel Blanco; Lady Ramírez; Daniel Garcerant; Adriana Cruz; Noah Craft; Nancy Gore Saravia
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

Review 3.  Animal models for the study of leishmaniasis immunology.

Authors:  Elsy Nalleli Loría-Cervera; Fernando José Andrade-Narváez
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

Review 4.  Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery.

Authors:  Arijit Bhattacharya; Audrey Corbeil; Rubens L do Monte-Neto; Christopher Fernandez-Prada
Journal:  Genes (Basel)       Date:  2020-06-29       Impact factor: 4.096

5.  The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice.

Authors:  Marcus Vinícius Alves-Silva; Dirlei Nico; Paula Melo de Luca; Clarisa B Palatnik de-Sousa
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

6.  Non-human primates and Leishmania immunity.

Authors:  Sonia André; Vasco Rodrigues; Morgane Picard; Ricardo Silvestre; Jérôme Estaquier
Journal:  Cytokine X       Date:  2020-10-12

Review 7.  A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.

Authors:  Emily Rose Mears; Farrokh Modabber; Robert Don; George E Johnson
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03

8.  Clinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigen.

Authors:  Gabriel Grimaldi; Antonio Teva; Renato Porrozzi; Marcelo A Pinto; Renato S Marchevsky; Maria Gabrielle L Rocha; Miriam S Dutra; Oscar Bruña-Romero; Ana-Paula Fernandes; Ricardo T Gazzinelli
Journal:  PLoS Negl Trop Dis       Date:  2014-06-19

9.  Dynamic of the cellular immune response at the dermal site of Leishmania (L.) amazonensis and Leishmania (V.) braziliensis infection in Sapajus apella primate.

Authors:  Márcia Dalastra Laurenti; Luiz Felipe Domingues Passero; Thaise Yumie Tomokane; Fernanda de Camargo Francesquini; Mussya Cisotto Rocha; Claudia Maria de Castro Gomes; Carlos Eduardo Pereira Corbett; Fernando Tobias Silveira
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

Review 10.  Lessons from other diseases: granulomatous inflammation in leishmaniasis.

Authors:  Paul M Kaye; Lynette Beattie
Journal:  Semin Immunopathol       Date:  2015-12-17       Impact factor: 9.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.